Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05729425 · ClinicalTrials.gov registry record
Evaluating the Accuracy of Microvessel Ultrasound Imaging for Detecting Extent of Disease in Patients With Angiosarcoma of the Skin
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 1
- Enrollment target
NCT05729425: Clinical Trial study, sponsored by Mayo Clinic.
NCT05729425 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05729425 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
This study evaluates the accuracy of a new ultrasound technology called microvessel imaging for detecting the extent of disease among patients with angiosarcoma of the skin. Microvessel ultrasound imaging uses high frequency waves to visualize vessels in the skin that are not easily seen using other imaging tests.
Interventions
- DEVICE Ultrasound Microvessel Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2022-10-31 |
| Est. Completion | 2023-08-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05729425
The ClinicalTrials.gov registry entry for NCT05729425 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ultrasound Microvessel Imaging is the first listed.
NCT05729425 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05729425 about?
NCT05729425 is a clinical study titled "Evaluating the Accuracy of Microvessel Ultrasound Imaging for Detecting Extent of Disease in Patients With Angiosarcoma of the Skin". This study evaluates the accuracy of a new ultrasound technology called microvessel imaging for detecting the extent of disease among patients with angiosarcoma of the skin. Microvessel ultrasound imaging uses high frequency waves to visualize vessels in the skin that are not easily seen using other...
What is the current status of trial NCT05729425?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2022-10-31. Estimated completion is 2023-08-15.
What interventions are being tested in trial NCT05729425?
The interventions under investigation include: Ultrasound Microvessel Imaging (DEVICE).
Who is sponsoring clinical trial NCT05729425?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.